Associated Papers
Type I Interferon Signature is Associated With Lung Disease, Drug-Associated Immune Reactions, and Genetic Variation in Interferon-Linked Pathways in Still Disease.
Marques MC et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
The evolutionary landscape of host immunity genes involved in respiratory and other immune-related diseases, and their association with severe COVID-19 outcomes.
Cross CN et al.
Medrxiv : the Preprint Server for Health Sciences, 2025
Relevance of Coding Variation in FLG And DOCK8 in Finnish Pediatric Patients with Early-Onset Moderate-To-Severe Atopic Dermatitis.
Perälä M et al.
Jid Innovations : Skin Science From Molecules to Population Health, 2023
37533579 (PubMed )
Supplement: mmc1.xlsx › Supplementary_Table_S1
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.
Trowbridge JJ et al.
The Journal of Experimental Medicine, 2021
SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes.
Sallman DA et al.
Clinical Lymphoma, Myeloma & Leukemia, 2017
Genetic variation of the Toll-like receptors in a Swedish allergic rhinitis case population.
Henmyr V et al.
Bmc Medical Genetics, 2017
28228119 (PubMed )
Supplement: 12881_2017_379_MOESM8_ESM.xlsx › TabS4
Genetic architecture differences between pediatric and adult-onset inflammatory bowel diseases in the Polish population.
Ostrowski J et al.
Scientific Reports, 2016
28008999 (PubMed )
Supplement: srep39831-s2.xls › Table_S7
Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution.
Bravo GM et al.
British Journal of Haematology, 2014
Toll-like receptor alterations in myelodysplastic syndrome.
Wei Y et al.
Leukemia, 2013
Select a paper to view details